Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Tots els drets reservats
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/193790
Chemical screen identifies FDA-approved drugs and target pathways that induce precocious pancreatic endocrine differentiation
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Pancreatic β-cells are an essential source of insulin and their destruction because of autoimmunity causes type I diabetes. We conducted a chemical screen to identify compounds that would induce the differentiation of insulin-producing β-cells in vivo. To do this screen, we brought together the use of transgenic zebrafish as a model of β-cell differentiation, a unique multiwell plate that allows easy visualization of lateral views of swimming larval fish and a library of clinical drugs. We identified six hits that can induce precocious differentiation of secondary islets in larval zebrafish. Three of these six hits were known drugs with a considerable background of published data on mechanism of action. Using pharmacological approaches, we have identified and characterized two unique pathways in β-cell differentiation in the zebrafish, including down-regulation of GTP production and retinoic acid biosynthesis.
Matèries (anglès)
Citació
Citació
ROVIRA, Meritxell, HUANG, Wei, YUSUFF, Shamila, SHIM, Joong sup, FERRANTE, Anthony a., LIU, Jun o., PARSONS, Michael j.. Chemical screen identifies FDA-approved drugs and target pathways that induce precocious pancreatic endocrine differentiation. _Proceedings of the National Academy of Sciences of the United States of America - PNAS_. 2011. Vol. 108, núm. 48. [consulta: 24 de gener de 2026]. ISSN: 0027-8424. [Disponible a: https://hdl.handle.net/2445/193790]